Agency Forms Undergoing Paperwork Reduction Act Review, 12119-12121 [2011-4946]

Download as PDF Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices that have the potential for use as agents of bioterrorism, inflicting significant morbidity and mortality on susceptible populations. In light of current terrorism concerns and the significant NIH grant monies directed toward Select Agent research, CDC receives hundreds of requests for Select Agents from researchers. The approximately 900 applicants are required to complete an application form in which they identify themselves and their institution, provide a Curriculum Vitae or biographical sketch, a summary of their research proposal, and sign indemnification and material transfer agreement statements. In this request, CDC is requesting approval for approximately 450 hours; no change from the currently approved 12119 burden. The only correction to this data collection request is updating the name of the National Center on the application form. A user fee will be collected to recover costs for materials, handling and shipping (except for public health laboratories). The cost to the respondent will vary based on which agent is requested. ESTIMATE OF ANNUALIZED BURDEN HOURS Respondent Number of respondents Number of responses per respondent Average burden per response (in hours) Researcher ...................................................................................................... Total .......................................................................................................... 900 ........................ 1 ........................ 30/60 ........................ Dated: February 25, 2011. Carol E. Walker, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2011–4948 Filed 3–3–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30-Day–11–0666] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. jlentini on DSKJ8SOYB1PROD with NOTICES Proposed Project National Healthcare Safety Network (NHSN) (OMB No. 0920–0666 exp. 3/31/2012)—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Healthcare Safety Network (NHSN) is a system designed to VerDate Mar<15>2010 19:16 Mar 03, 2011 Jkt 223001 accumulate, exchange, and integrate relevant information and resources among private and public stakeholders to support local and national efforts to protect patients and to promote healthcare safety. Specifically, the data is used to determine the magnitude of various healthcare-associated adverse events and trends in the rates of these events among patients and healthcare workers with similar risks. Healthcare institutions that participate in NHSN voluntarily report their data to CDC using a web browser based technology for data entry and data management. Data are collected by trained surveillance personnel using written standardized protocols. The data will be used to detect changes in the epidemiology of adverse events resulting from new and current medical therapies and changing risks. This revision submission includes an amended Assurance of Confidentiality, which required an update of the Assurance of Confidentiality language on all forms included in the NHSN surveillance system. The scope of NHSN dialysis surveillance is being expanded to include all outpatient dialysis centers so that the existing Dialysis Annual Survey can be used to facilitate prevention objectives set forth in the HHS HAI tier 2 Action Plan and to assess national practices in all Medicare-certified dialysis centers if CMS re-establishes this survey method (as expected). The Patient Safety (PS) Component is being expanded to include long term care facilities to facilitate HAI surveillance in this setting, for which no standardized reporting methodology or mechanism currently exists. Four new forms are PO 00000 Frm 00107 Fmt 4703 Sfmt 4703 Total burden (in hours) 450 450 proposed for this purpose. A new form is proposed to be added to the Healthcare Personnel Safety (HPS) Component to facilitate summary reporting of influenza vaccination in healthcare workers, which is anticipated to be required by CMS in the near future. In addition to this new form, the scope of the HPS Annual Facility Survey is being expanded to include all acute care facilities that would enroll if CMS does implement this requirement. The NHSN Antimicrobial Use and Resistance module is transitioning from manual web entry to electronic data upload only, which results in a significant decrease to the reporting burden for this package. Finally, there are many updates, clarifications, and data collection revisions proposed in this submission. CDC is requesting to delete four currently approved forms that are no longer needed by the NHSN and add five new forms The previously-approved NHSN package included 47 individual data collection forms. If all proposed revisions are approved, the reporting burden will decrease by 1,258,119 hours, for a total estimated burden of 3,914,125 hours and 48 total data collection tools. Participating institutions must have a computer capable of supporting an Internet service provider (ISP) and access to an ISP. There is no cost to respondents other than their time. The total estimated annual burden hours are 3,914,125. E:\FR\FM\04MRN1.SGM 04MRN1 12120 Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices ESTIMATE OF ANNUALIZED BURDEN HOURS Number of respondents Respondents Form name Infection Preventionist ............ NHSN Registration Form ....................................................... Facility Contact Information .................................................... Patient Safety Component—Annual Facility Survey .............. Patient Safety Component—Outpatient Dialysis Center Practices Survey. Group Contact Information ..................................................... Patient Safety Monthly Reporting Plan .................................. Primary Bloodstream Infection (BSI) ...................................... Dialysis Event ......................................................................... Pneumonia (PNEU) ................................................................ Urinary Tract Infection (UTI) .................................................. Denominators for Neonatal Intensive Care Unit (NICU) ........ Denominators for Specialty Care Area (SCA) ....................... Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA). Denominator for Outpatient Dialysis ...................................... Surgical Site Infection (SSI) ................................................... Denominator for Procedure .................................................... Antimicrobial Use and Resistance (AUR)-Microbiology Data Electronic Upload Specification Tables. Antimicrobial Use and Resistance (AUR)-Pharmacy Data Electronic Upload Specification Tables. Central Line Insertion Practices Adherence Monitoring ........ MDRO or CDI Infection Form ................................................ MDRO and CDI Prevention Process and Outcome Measures Monthly Monitoring. Laboratory-identified MDRO or CDI Event ............................ Vaccination Monthly Monitoring Form—Summary Method ... Vaccination Monthly Monitoring Form—Patient-Level Method. Patient Vaccination ................................................................. Patient Safety Component—Annual Facility Survey for LTCF. Laboratory-identified MDRO or CDI Event for LTCF ............. MDRO and CDI Prevention Process Measures Monthly Monitoring for LTCF. Urinary Tract Infection (UTI) for LTCF ................................... Healthcare Personnel Safety Component Annual Facility Survey. Healthcare Worker Survey ..................................................... Healthcare Personnel Safety Monthly Reporting Plan .......... Healthcare Worker Demographic Data .................................. Exposure to Blood/Body Fluids .............................................. Healthcare Worker Prophylaxis/Treatment ............................ Follow-Up Laboratory Testing ................................................ Healthcare Worker Vaccination History ................................. Healthcare Worker Influenza Vaccination .............................. Healthcare Worker Prophylaxis/Treatment-Influenza ............ Pre-season Survey on Influenza Vaccination Programs for Healthcare Personnel. Post-season Survey on Influenza Vaccination Programs for Healthcare Personnel. Healthcare Personnel Influenza Vaccination Monthly Summary. Hemovigilance Module Annual Survey .................................. Staff RN .................................. Staff RN .................................. Infection Preventionist ............ Staff RN .................................. Laboratory Technician ............ Pharmacy Technician ............. Infection Preventionist ............ Occ Health RN ........................ Laboratory Technician ............ Occ Health RN ........................ Occ Health RN ........................ Clinical Laboratory Technologist. jlentini on DSKJ8SOYB1PROD with NOTICES Hemovigilance Hemovigilance Hemovigilance Hemovigilance Hemovigilance VerDate Mar<15>2010 19:16 Mar 03, 2011 Jkt 223001 Module Monthly Reporting Plan .................... Module Monthly Incident Summary ............... Module Monthly Reporting Denominators ..... Adverse Reaction .......................................... Incident .......................................................... PO 00000 Frm 00108 Fmt 4703 Sfmt 4703 E:\FR\FM\04MRN1.SGM Responses per respondent Burden per response (hours) 6,000 6,000 6,000 5,500 1 1 1 1 5/60 10/60 40/60 1 6,000 6,000 6,000 500 6,000 6,000 6,000 6,000 6,000 1 9 36 75 72 27 9 9 18 5/60 35/60 32/60 15/60 32/60 32/60 4 5 5 500 6,000 6,000 6,000 12 27 540 12 5/60 32/60 10/60 5/60 6,000 12 5/60 6,000 6,000 6,000 100 72 24 5/60 32/60 10/60 6,000 6,000 2,000 240 5 5 25/60 14 2 2,000 250 250 1 10/60 25/60 250 250 8 3 30/60 7/60 250 6,000 9 1 30/60 8 600 600 600 600 600 600 600 600 600 600 100 9 200 50 10 100 300 500 50 1 10/60 10/60 20/60 1 15/60 15/60 10/60 10/60 10/60 10/60 600 1 10/60 6,000 6 2 500 1 2 500 500 500 500 500 12 12 12 120 72 2/60 2 30/60 10/60 10/60 04MRN1 12121 Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices Dated: February 25, 2011. Catina Conner, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2011–4946 Filed 3–3–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30-Day–11–0770] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an e-mail to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project National HIV Behavioral Surveillance System (NHBS) 0920–0770 (exp. 03/31/ 2011)—Revision-National Center for HIV, Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The purpose of this data collection is to monitor behaviors related to human immunodeficiency virus (HIV) infection among persons at high risk for infection in the United States. The primary objectives of NHBS are to obtain data from samples of persons at risk to: (a) Describe the prevalence and trends in risk behaviors; (b) describe the prevalence of and trends in HIV testing and HIV infection; (c) describe the prevalence of and trends in use of HIV prevention services; (d) identify met and unmet needs for HIV prevention services in order to inform health departments, community-based organizations, community planning groups and other stakeholders. This project addresses the goals of CDC’s HIV prevention strategic plan, specifically the goal of strengthening the national capacity to monitor the HIV epidemic to better direct and evaluate prevention efforts. For the proposed data collection, CDC has revised the interview data collection instruments. A few questions were added (related to health care access and utilization, use of pre-exposure prophylaxis, homophobia, HIV stigma, and discrimination), some were removed, and others were revised from the previously approved instrument to make them easier for respondents to understand and respond appropriately. The project activities and methods will remain the same as those used in the previously approved collection. Data are collected through anonymous, in-person interviews conducted with persons systematically selected from 25 Metropolitan Statistical Areas (MSAs) throughout the United States; these 25 MSAs were chosen based on having high AIDS prevalence. Persons at risk for HIV infection to be interviewed for NHBS include men who have sex with men (MSM), injecting drug users (IDUs), and heterosexuals at increased risk of HIV (HET). A brief screening interview will be used to determine eligibility for participation in the behavioral assessment. The data from the behavioral assessment will provide estimates of behavior related to the risk of HIV and other sexually transmitted diseases, prior testing for HIV, and use of HIV prevention services. All persons interviewed will also be offered an HIV test and will participate in a pre-test counseling session. No other Federal agency systematically collects this type of information from persons at risk for HIV infection. These data have substantial impact on prevention program development and monitoring at the local, State, and national levels. CDC estimates that NHBS will involve, per year in each of the 25 MSAs, eligibility screening for 50 to 200 persons and eligibility screening plus the survey with 500 eligible respondents, resulting in a total of 37,500 eligible survey respondents and 7,500 ineligible screened persons during a 3-year period. Data collection will rotate such that interviews will be conducted among one group per year: MSM in year 1, IDU in year 2, and HET in year 3. The type of data collected for each group will vary slightly due to different sampling methods and risk characteristics of the group. This request is for a revision and an approval for an additional 3 years of data collection. Participation of respondents is voluntary and there is no cost to the respondents other than their time. The total estimated annualized burden hours are 9,931. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Responses per respondent Average burden per response (in hours) Screener ............................... Survey ................................... 17,500 12,500 1 1 5/60 30/60 Screener ............................... Survey ................................... Recruiter Debriefing .............. 13,750 12,500 6,250 1 1 1 5/60 54/60 2/60 Screener ............................... Survey ................................... Recruiter Debriefing .............. 13,750 12,500 6,250 1 1 1 5/60 39/60 2/60 jlentini on DSKJ8SOYB1PROD with NOTICES Type of respondent Form name Year 1 (MSM): Persons Screened ......................................................................... Eligible Participants ....................................................................... Year 2 (IDU). Persons Referred by Peer Recruiters ........................................... Eligible Participants ....................................................................... Peer Recruiters ............................................................................. Year 3 (HET): Persons Referred by Peer Recruiters ........................................... Eligible Participants ....................................................................... Peer Recruiters ............................................................................. VerDate Mar<15>2010 19:16 Mar 03, 2011 Jkt 223001 PO 00000 Frm 00109 Fmt 4703 Sfmt 4703 E:\FR\FM\04MRN1.SGM 04MRN1

Agencies

[Federal Register Volume 76, Number 43 (Friday, March 4, 2011)]
[Notices]
[Pages 12119-12121]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4946]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30-Day-11-0666]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-5806. 
Written comments should be received within 30 days of this notice.

Proposed Project

    National Healthcare Safety Network (NHSN) (OMB No. 0920-0666 exp. 
3/31/2012)--Revision--National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The National Healthcare Safety Network (NHSN) is a system designed 
to accumulate, exchange, and integrate relevant information and 
resources among private and public stakeholders to support local and 
national efforts to protect patients and to promote healthcare safety. 
Specifically, the data is used to determine the magnitude of various 
healthcare-associated adverse events and trends in the rates of these 
events among patients and healthcare workers with similar risks. 
Healthcare institutions that participate in NHSN voluntarily report 
their data to CDC using a web browser based technology for data entry 
and data management. Data are collected by trained surveillance 
personnel using written standardized protocols. The data will be used 
to detect changes in the epidemiology of adverse events resulting from 
new and current medical therapies and changing risks.
    This revision submission includes an amended Assurance of 
Confidentiality, which required an update of the Assurance of 
Confidentiality language on all forms included in the NHSN surveillance 
system. The scope of NHSN dialysis surveillance is being expanded to 
include all outpatient dialysis centers so that the existing Dialysis 
Annual Survey can be used to facilitate prevention objectives set forth 
in the HHS HAI tier 2 Action Plan and to assess national practices in 
all Medicare-certified dialysis centers if CMS re-establishes this 
survey method (as expected). The Patient Safety (PS) Component is being 
expanded to include long term care facilities to facilitate HAI 
surveillance in this setting, for which no standardized reporting 
methodology or mechanism currently exists. Four new forms are proposed 
for this purpose. A new form is proposed to be added to the Healthcare 
Personnel Safety (HPS) Component to facilitate summary reporting of 
influenza vaccination in healthcare workers, which is anticipated to be 
required by CMS in the near future. In addition to this new form, the 
scope of the HPS Annual Facility Survey is being expanded to include 
all acute care facilities that would enroll if CMS does implement this 
requirement. The NHSN Antimicrobial Use and Resistance module is 
transitioning from manual web entry to electronic data upload only, 
which results in a significant decrease to the reporting burden for 
this package. Finally, there are many updates, clarifications, and data 
collection revisions proposed in this submission.
    CDC is requesting to delete four currently approved forms that are 
no longer needed by the NHSN and add five new forms
    The previously-approved NHSN package included 47 individual data 
collection forms. If all proposed revisions are approved, the reporting 
burden will decrease by 1,258,119 hours, for a total estimated burden 
of 3,914,125 hours and 48 total data collection tools.
    Participating institutions must have a computer capable of 
supporting an Internet service provider (ISP) and access to an ISP. 
There is no cost to respondents other than their time. The total 
estimated annual burden hours are 3,914,125.

[[Page 12120]]



                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                    Burden per
            Respondents                       Form name              Number of     Responses per     response
                                                                    respondents     respondent        (hours)
----------------------------------------------------------------------------------------------------------------
Infection Preventionist............  NHSN Registration Form.....           6,000               1            5/60
                                     Facility Contact                      6,000               1           10/60
                                      Information.
                                     Patient Safety Component--            6,000               1           40/60
                                      Annual Facility Survey.
                                     Patient Safety Component--            5,500               1               1
                                      Outpatient Dialysis Center
                                      Practices Survey.
                                     Group Contact Information..           6,000               1            5/60
                                     Patient Safety Monthly                6,000               9           35/60
                                      Reporting Plan.
                                     Primary Bloodstream                   6,000              36           32/60
                                      Infection (BSI).
                                     Dialysis Event.............             500              75           15/60
                                     Pneumonia (PNEU)...........           6,000              72           32/60
                                     Urinary Tract Infection               6,000              27           32/60
                                      (UTI).
Staff RN...........................  Denominators for Neonatal             6,000               9               4
                                      Intensive Care Unit (NICU).
                                     Denominators for Specialty            6,000               9               5
                                      Care Area (SCA).
                                     Denominators for Intensive            6,000              18               5
                                      Care Unit (ICU)/Other
                                      locations (not NICU or
                                      SCA).
Staff RN...........................  Denominator for Outpatient              500              12            5/60
                                      Dialysis.
Infection Preventionist............  Surgical Site Infection               6,000              27           32/60
                                      (SSI).
Staff RN...........................  Denominator for Procedure..           6,000             540           10/60
Laboratory Technician..............  Antimicrobial Use and                 6,000              12            5/60
                                      Resistance (AUR)-
                                      Microbiology Data
                                      Electronic Upload
                                      Specification Tables.
Pharmacy Technician................  Antimicrobial Use and                 6,000              12            5/60
                                      Resistance (AUR)-Pharmacy
                                      Data Electronic Upload
                                      Specification Tables.
Infection Preventionist............  Central Line Insertion                6,000             100            5/60
                                      Practices Adherence
                                      Monitoring.
                                     MDRO or CDI Infection Form.           6,000              72           32/60
                                     MDRO and CDI Prevention               6,000              24           10/60
                                      Process and Outcome
                                      Measures Monthly
                                      Monitoring.
                                     Laboratory-identified MDRO            6,000             240           25/60
                                      or CDI Event.
                                     Vaccination Monthly                   6,000               5              14
                                      Monitoring Form--Summary
                                      Method.
                                     Vaccination Monthly                   2,000               5               2
                                      Monitoring Form--Patient-
                                      Level Method.
                                     Patient Vaccination........           2,000             250           10/60
                                     Patient Safety Component--              250               1           25/60
                                      Annual Facility Survey for
                                      LTCF.
                                     Laboratory-identified MDRO              250               8           30/60
                                      or CDI Event for LTCF.
                                     MDRO and CDI Prevention                 250               3            7/60
                                      Process Measures Monthly
                                      Monitoring for LTCF.
                                     Urinary Tract Infection                 250               9           30/60
                                      (UTI) for LTCF.
Occ Health RN......................  Healthcare Personnel Safety           6,000               1               8
                                      Component Annual Facility
                                      Survey.
                                     Healthcare Worker Survey...             600             100           10/60
                                     Healthcare Personnel Safety             600               9           10/60
                                      Monthly Reporting Plan.
                                     Healthcare Worker                       600             200           20/60
                                      Demographic Data.
                                     Exposure to Blood/Body                  600              50               1
                                      Fluids.
                                     Healthcare Worker                       600              10           15/60
                                      Prophylaxis/Treatment.
Laboratory Technician..............  Follow-Up Laboratory                    600             100           15/60
                                      Testing.
Occ Health RN......................  Healthcare Worker                       600             300           10/60
                                      Vaccination History.
Occ Health RN......................  Healthcare Worker Influenza             600             500           10/60
                                      Vaccination.
                                     Healthcare Worker                       600              50           10/60
                                      Prophylaxis/Treatment-
                                      Influenza.
                                     Pre-season Survey on                    600               1           10/60
                                      Influenza Vaccination
                                      Programs for Healthcare
                                      Personnel.
                                     Post-season Survey on                   600               1           10/60
                                      Influenza Vaccination
                                      Programs for Healthcare
                                      Personnel.
                                     Healthcare Personnel                  6,000               6               2
                                      Influenza Vaccination
                                      Monthly Summary.
Clinical Laboratory Technologist...  Hemovigilance Module Annual             500               1               2
                                      Survey.
                                     Hemovigilance Module                    500              12            2/60
                                      Monthly Reporting Plan.
                                     Hemovigilance Module                    500              12               2
                                      Monthly Incident Summary.
                                     Hemovigilance Module                    500              12           30/60
                                      Monthly Reporting
                                      Denominators.
                                     Hemovigilance Adverse                   500             120           10/60
                                      Reaction.
                                     Hemovigilance Incident.....             500              72           10/60
----------------------------------------------------------------------------------------------------------------



[[Page 12121]]

    Dated: February 25, 2011.
Catina Conner,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2011-4946 Filed 3-3-11; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.